Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.015
Sell
RSI(14)
45.414
Neutral
STOCH(KDJ)(9,3,3)
56.695
Buy
ATR(14)
0.302
Low Volatility
CCI(14)
18.504
Neutral
Williams %R
48.454
Neutral
TRIX(12,20)
-0.213
Sell
StochRSI(14)
69.362
Sell
SWK Holdings Corp
SWKH14.680USD
+0.270+1.87%
Market hours （ET）Quotes delayed by 15 min
178.86MMarket Cap
9.79P/E TTM
TradingKey Stock Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Peers
TradingKey Stock Score
Currency: USD Updated：2025-08-26Key Insights
The company's fundamentals are relatively weak.Its valuation is considered fairly valued,and institutional recognition is very high.Over the past 30 days, multiple analysts have rated the company as a Buy.Despite an average stock market performance, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analysts' Target
Based on
1
analysts
Buy
Current Rating
18.500
Target Price
+27.85%
Upside Space
Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies, the Peptelligence platform.
Growing
The company is in a growing phase, with the latest annual income totaling USD 44.99M.
Undervalued
The company’s latest PE is 10.16, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 11.55M shares, increasing 3.48% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 201.06K shares of this stock.
Financial Health
Currency: USD Updated：2025-08-26The company's current financial score is 6.36, which is lower than the Banking & Investment Services industry's average of 7.33. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 11.83M, representing a year-over-year increase of 4.15%, while its net profit experienced a year-over-year increase of 869.87%.
Score
Financials
2.10
Related Indicators
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.78
Operational Efficiency
7.63
Growth Potential
7.20
Shareholder Returns
7.11
Valuation Dimension
Currency: USD Updated：2025-08-26The company’s current valuation score is 6.40, which is higher than the Banking & Investment Services industry's average of 5.18. Its current P/E ratio is 10.16, which is 37.49% below the recent high of 13.97 and -3.68% above the recent low of 10.53.
Score
Valuation Dimension
P/E
P/B
P/S
P/CF
Industry Ranking 82/524
No Data
Forecast
Currency: USD Updated：2025-08-26The company’s current earnings forecast score is 8.00, which is higher than the Banking & Investment Services industry's average of 7.34. The average price target for SWK Holdings Corp is 18.50, with a high of 18.50 and a low of 18.50.
Score
Support & Resistance
No Data
Analyst Rating
Based on
1
analysts
Buy
Current Rating
18.500
Target Price
+27.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
15
Total
5
Median
4
Average
Company name
Ratings
Analysts
SWK Holdings Corp
SWKH
1
Runway Growth Finance Corp
RWAY
10
AerCap Holdings NV
AER
10
Air Lease Corp
AL
7
MSC Income Fund Inc
MSIF
6
NewtekOne Inc
NEWT
6
1
2
3
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Momentum
Currency: USD Updated：2025-08-26The company’s current price momentum score is 6.85, which is lower than the Banking & Investment Services industry's average of 8.70. Sideways: Currently, the stock price is trading between the resistance level at 15.09 and the support level at 13.82, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
14.352
Buy
MA10
14.347
Buy
MA20
14.566
Buy
MA50
14.816
Sell
MA100
14.446
Buy
MA200
13.736
Buy
Institutional Confidence
Currency: USD Updated：2025-08-26The company’s current institutional recognition score is 10.00, which is higher than the Banking & Investment Services industry's average of 6.35. The latest institutional shareholding proportion is 94.17%, representing a quarter-over-quarter increase of 0.38%. The largest institutional shareholder is The Vanguard, holding a total of 201.06K shares, representing 1.66% of shares outstanding, with 13.72% decrease in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
Carlson Capital, L.P.
M3F, Inc.
Carlson (Clint Duane)
Cannell Capital, LLC
BlackRock Institutional Trust Company, N.A.
Staggs (Joe David JR)
Bridgeway Capital Management, LLC
Geode Capital Management, L.L.C.
1
2
Risk Assessment
Currency: USD Updated：2025-08-26The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Banking & Investment Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 6.56, which is higher than the Banking & Investment Services industry's average of 5.16. The company's beta value is 0.17. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.17
VaR
+2.49%
240-Day Maximum Drawdown
+12.75%
240-Day Volatility
+35.67%
Return
Best Daily Return
60 days
+4.85%
120 days
+22.59%
5 years
+22.59%
Worst Daily Return
60 days
-3.50%
120 days
-5.75%
5 years
-10.78%
Sharpe Ratio
60 days
+0.52
120 days
+1.79
5 years
+0.45
Risk Assessment
Maximum Drawdown
240 days
+12.75%
3 years
+23.51%
5 years
+23.97%
Return-to-Drawdown Ratio
240 days
+0.59
3 years
+0.11
5 years
+0.18
Skewness
240 days
+5.14
3 years
+3.37
5 years
+1.80
Volatility
Realised Volatility
240 days
+35.67%
5 years
+35.82%
Standardised True Range
240 days
+2.40%
5 years
+2.53%
Downside Risk-Adjusted Return
120 days
+458.41%
240 days
+458.41%
Maximum Daily Upside Volatility
60 days
+16.87%
Maximum Daily Downside Volatility
60 days
+17.04%
Liquidity
Average Turnover Rate
60 days
+0.12%
120 days
+0.15%
5 years
--
Turnover Deviation
20 days
+17.87%
60 days
+27.10%
120 days
+59.34%
Peers
Currency: USD Updated：2025-08-26SWK Holdings Corp
SWKH
7.18 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Bank of New York Mellon Corp
BK
8.20 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Wintrust Financial Corp
WTFC
8.11 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Synchrony Financial
SYF
8.09 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Affiliated Managers Group Inc
AMG
8.08 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
Credicorp Ltd
BAP
8.07 /10
Score
Financial Health
Valuation Dimension
Forecast
Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
